Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer

Cardiovascular Complications of Systemic Therapy in Non-Small-Cell Lung Cancer

Cardiovascular diseases may determine therapy outcomes of non-small-cell lung cancer (NSCLC). The evidence for how iatrogenic cardiovascular complications contribute to ceasing anticancer treatment, decreasing the quality of life or even premature death, is unclear. Older patients and smokers are at...

Full description

Bibliographic Details
Main Authors: Magdalena Zaborowska-Szmit, Maciej Krzakowski, Dariusz M. Kowalski, Sebastian Szmit
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Journal of Clinical Medicine
Subjects:
cardio-oncology
NSCLC
thromboembolic events
heart failure
acute coronary syndrome
myocarditis
Online Access:https://www.mdpi.com/2077-0383/9/5/1268

Internet

https://www.mdpi.com/2077-0383/9/5/1268

Similar Items